Comprehensive and Methodical: Diagnostic and Management Approaches to Rapidly Progressive Dementia
- 30 September 2017
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Neurology
- Vol. 19 (11) , 40
Abstract
Purpose of review The sudden emergence of a change in cognitive abilities or behavior is an important symptom that warrants medical evaluation and may represent the early stages of a rapidly progressive dementia (RPD). To correctly ascertain the cause of RPD in a given patient, the clinician must be methodical and knowledgeable about the range of potential causes and must move forward with supportive treatment, and in some cases empiric treatment, based on clinical features alone. Recent findings Significant advances in prion disease biomarkers, the molecular features of rapidly progressive Alzheimer’s disease, and new detection of autoimmune limbic encephalitis disease entities have caused a shift in the diagnostic and treatment framework of RPD. Additionally, in the past decade, emerging retrospective data have led to suggested treatments in autoimmune encephalitis that, if instituted early, can protect patients against residual deficits and disease relapse. Summary Here, we provide an integrative clinical and diagnostic treatment approach that is applicable to the various forms of RPD. We have highlighted the clinical features of selected types of RPD that have experienced advances in the last 10–15 years.Keywords
This publication has 69 references indexed in Scilit:
- Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected MiceMolecular Therapy Nucleic Acids, 2012
- Treatable neurological disorders misdiagnosed as Creutzfeldt‐Jakob diseaseAnnals of Neurology, 2011
- Variably protease‐sensitive prionopathy: A new sporadic disease of the prion proteinAnnals of Neurology, 2010
- Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesThe Lancet Neurology, 2010
- Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotoniaBrain, 2010
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trialThe Lancet Neurology, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Rapidly progressive dementiaAnnals of Neurology, 2008
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007